Innorna
PrivateLast Round
IPO
Oct 22, 2025
Est. Valuation
$480M
Total Funding Raised
$120M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Innorna is a biotechnology company that develops mRNA-based medicines and proprietary lipid nanoparticle (LNP) delivery systems to treat chronic diseases, power in vivo immunotherapies, and prevent infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innorna Comparables
Compare Innorna with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immorna Biotherapeutics | 89% | |
| Immorna | 88% | |
| RVAC Medicines | 88% |
Innorna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Oct 22, 2025 | ||||
| Series B | Mar 28, 2022 | ||||
| Series A | Jul 22, 2021 | ||||
| Angel | Nov 1, 2020 |
Innorna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Optimas Capital | Series B |
| Huasheng Capital | Series B |
| Hong Kong Science and Technology Parks Corporation | Series B |
| Legend Capital | Series A |
| CITIC Private Equity Funds Management | Series B |
| Fangyuan Capital (Hong Kong) Limited | Series B |
| CAS Star | Series A, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 86% MoM.
- Jul 27, 2026
Monthly visitors grew 137% MoM, reaching 1K.
Recent news
Latest coverage and updates
- receives_financingAug 13, 2026
Innorna Co. receives financing of $150M in equity financing.
- recognized_asAug 13, 2026
Linxian Li at Innorna Co. recognized as Prix Galien USA Best Startup nominee at 2026 Prix Galien USA Awards on Aug 13th '26.
- recognized_asAug 13, 2026
Innorna Co. recognized as Best Startup category at 2026 Prix Galien USA Awards on Aug 13th '26.
- recognized_asAug 13, 2026
Innorna Co. recognized as Best... on Aug 13th '26.
- receives_awardAug 13, 2026
Innorna Co. received award 2026 Prix Galien USA Best Startup Award at 2026 Prix Galien USA Awards on Aug 13th '26.
Innorna Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Innorna's valuation, stock price, and market status.
Is Innorna a public or private company?
Innorna is a private company.
What is the current stock price of Innorna?
Innorna is a private company with no public stock price. No recent secondary market data is available.
How much is Innorna worth (valuation)?
Valuation information for Innorna is not publicly available.
Can I buy Innorna stock?
Innorna shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Innorna's last funding round?
Innorna's most recent funding round was Series B on March 28, 2022.
Who are the main investors in Innorna?
Key investors in Innorna include Huasheng Capital, CDH Investments, CPE (CPE源峰).
Will Innorna IPO soon?
No public IPO plans have been announced for Innorna.
How can I track Innorna secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Innorna's secondary market activity and sign up for updates.